FDA announces new efforts to expedite generic drug development and marketing to improve patient access to medicines

10 July 2019 - Today, the U.S. FDA announced a draft guidance, Harmonizing Compendial Standards With Drug Application Approval Using the ...

Read more →

Delays a matter of life and death

1 July 2019 - The shocking news that Aussie cancer patients are facing long waits for essential medicines is cause for ...

Read more →

Why it takes five years for life saving medicines to get funded

30 June 2019 - Cancer patients are waiting up to five years to access life-saving medicines as spending on the ...

Read more →

Delayed patient access to innovative medical technologies in South Korea: a lead-time analysis of reimbursement coverage determinations

20 June 2019 - Timely access to innovative medical technologies driven by accelerated patient access pathways can substantially improve the health ...

Read more →

Should the FDA speed up or slow down approval of new cancer drugs?

21 June 2019 - Earlier this month, the FDA announced the creation of Project Facilitate.  ...

Read more →

Game-changing cancer drugs which can attack all tumours will be fast-tracked by NHS

19 June 2019 - Game-changing cancer drugs which can attack all types of tumour will be fast-tracked by the NHS, ...

Read more →

Atomoxetine – delay in change of funded brand and open access

19 June 2019 - PHARMAC is advising all interested parties that there will be a delay in the listing of ...

Read more →

Updated PBAC Calendar and publication of Stage 1 PBS Process Improvements – Procedure Guidance and supporting documents

17 June 2019 - The Department of Health and Medicines Australia have been working since late 2017 to deliver on ...

Read more →

US FDA review for Scenesse extended by three months

3 June 2019 - The FDA sets new goal date of 6 October 2019 to complete review and issue risk-benefit decision. ...

Read more →

Korean Government to reduce biopharmaceutical approval period to half

20 May 2019 - The Korean government plans to reduce by half the current one and a half years of ...

Read more →

Helping Canadians get faster access to the prescription drugs they need to live healthier lives

13 May 2019 - Government of Canada consults on new approach to fast-track the review of treatments for serious, rare ...

Read more →

Speed up cancer funding, ALP told

11 May 2019 - The head of Australian drug company Specialised Therapeutics, Carlo Montagner, has warned that Bill Shorten’s cancer ...

Read more →

Canadians will wait longer for new medicines if Health Canada gets its way

23 April 2019 - The intention is to lower prices; the net result will likely be longer wait times before new ...

Read more →

Additional embargo period following revised CDEC recommendations

17 April 2019 - Effective immediately, CADTH has revised its procedures for the CADTH Common Drug Review to permit an ...

Read more →

PHARMAC's early access scheme needs work - Prime Minister Jacinda Ardern

16 April 2019 - Prime Minister Jacinda Ardern admits work needs to be done on PHARMAC's early access scheme, but ...

Read more →